Dermatology
Latest News
While Rare, Periocular Melanoma May Be Slightly Increasing
Most cases involve the intraocular part of the eye and the uvea.
Latest News
A Neurotoxin, an Antidepressant, and More Emerging Options for Treating Rosacea
Uptake in serotonin and changes in receptors are closely related to vascular dilation and constriction, so paroxetine "may be beneficial in...
Latest News
Expert Shares Tips for Diagnosing, Managing Spitz Nevi
Nodal metastases from atypical Spitzoid tumors are not uncommon, but death from widespread disease is rare, Dr. Caroline Piggott said.
Latest News
AAD Updates Guidelines for Managing Acne
“RCTs with long-term follow-up and comparative effectiveness research are necessary to examine and compare patient-centered acne treatment...
Latest News
More Than 100K New Cutaneous Melanoma Diagnoses Expected in 2024
Individuals can track their UV exposure with a variety of wearable devices and apps.
Latest News
New Tools on the Horizon for Managing cSCC in Solid Organ Transplant Recipients
Immune checkpoint inhibitors offer promise but organ rejection still a major concern with their use.
Latest News
Review Finds No Short-term MACE, VTE risk with JAK Inhibitors For Dermatoses
Meta-analysis suggests short-term use does not increase cardiovascular or thrombotic risk in people being treated for dermatological conditions....
Latest News
National Rosacea Society adds imprimatur to skin products
Seal of Acceptance is designed to identify products suitable for sensitive and redness-prone skin.
Latest News
Treating Acne Scars Can Improve Aesthetics, Quality of Life
Different approaches may be required even for the same patient because some people present with all three types of acne scars, said Robyn...
Latest News
Study Concludes Most Melanoma Overdiagnoses Are In Situ
The increase in melanoma diagnoses in the United States, while mortality has remained flat, has raised concerns about overdiagnosis of melanoma,...
Latest News
Rituximab Results in Sustained Remission for Pemphigus, Study Found
Disease-free survival statistically favored patients in the rituximab-plus-prednisone group compared with patients in the prednisone-only group at...